Medtecs International, on Jan 14, signed a letter of intent (LOI) with Enimmune Corporation, where both companies seek to leverage on each other’s strengths to explore opportunities to market and promote Enimmune’s “Speedy Covid-19 Ag Rapid Test” in the Philippines.

Enimmune is a joint venture vaccine development and marketing company that is jointly established by Adimmune Corporation and other venture capital investors.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook